Cescon DW, Hilton J, Morales Murilo S, Layman RM, et al. A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2-) Advanced or Metastatic Breast Cancer. Clin Cancer Res 2023 Nov 22. doi: 10.1158/1078-0432.CCR-23-0133.
PMID: 37992310